Overview

Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study

Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
To examine in Arista hemostatic powder results in less post-total knee arthroplasty blood loss, hematoma formation, and improved range of motion when compared to patients who did not receive the product.
Phase:
Phase 1
Details
Lead Sponsor:
Virtua Health, Inc.
Collaborator:
Becton, Dickinson and Company